<b>Conclusion:</b> The results of our meta-analysis indicate that high PD-L1 expression might serve as a valuable and predictive biomarker for adverse clinicopathological features and poor prognosis in patients with sarcoma. The gene discussed is CD274; the disease is sarcoma.